Related references
Note: Only part of the references are listed.Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood-Brain Barrier Model and in Alzheimer's Disease Tg2576 Mice
Kwok Kin Cheng et al.
AAPS JOURNAL (2013)
In Vitro Amyloid Aggregate Forming Ability of TGFBI Mutants that Cause Corneal Dystrophies
Gary Hin-Fai Yam et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease
Qin Nie et al.
ACTA PHARMACOLOGICA SINICA (2011)
Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease
Antero Salminen et al.
PROGRESS IN NEUROBIOLOGY (2011)
Heart complications in familial transthyretin amyloidosis: impact of age and gender
Rolf Hornsten et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2010)
Anti-tau oligomers passive vaccination for the treatment of Alzheimer disease
Rakez Kayed
HUMAN VACCINES (2010)
The Hsp40 J-domain Stimulates Hsp70 When Tethered by the Client to the ATPase Domain
B. Erin Horne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Neuroprotective Effect of Honokiol and Magnolol, Compounds from Magnolia officinalis, on Beta-amyloid-induced Toxicity in PC12 Cells
Chu Peng Hoi et al.
PHYTOTHERAPY RESEARCH (2010)
Neuroprotective activity and evaluation of Hsp90 inhibitors in an immortalized neuronal cell line
Yuanming Lu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
The Molecular Chaperone Hsp90 Modulates Intermediate Steps of Amyloid Assembly of the Parkinson-related Protein α-Synuclein
S. Fabio Falsone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The amyloid hypothesis for Alzheimer's disease: a critical reappraisal
John Hardy
JOURNAL OF NEUROCHEMISTRY (2009)
Chemical Manipulation of Hsp70 ATPase Activity Regulates Tau Stability
Umesh K. Jinwal et al.
JOURNAL OF NEUROSCIENCE (2009)
Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies
Kurt R. Brunden et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Dimethyl sulfoxide (DMSO) produces widespread apoptosis in the developing central nervous system
Jennifer L. Hanslick et al.
NEUROBIOLOGY OF DISEASE (2009)
Amyloid oligomers in diabetic and nondiabetic human pancreas
Hai-Lu Zhao et al.
TRANSLATIONAL RESEARCH (2009)
Gender-related risk of myocardial involvement in systemic amyloidosis
Claudio Rapezzi et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2008)
Development and application of Hsp90 inhibitors
David B. Solit et al.
DRUG DISCOVERY TODAY (2008)
Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones
Nobuhiro Fujikake et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Higher Islet Amyloid Load in Men Than in Women With Type 2 Diabetes Mellitus
Hai-Lu Zhao et al.
PANCREAS (2008)
Extracellular heat shock protein 70 inhibits tumour necrosis factor-alpha induced proinflammatory mediator production in fibroblast-like synoviocytes
Xinjing Luo et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: A phase I Dose-Escalation study
Shanu Modi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies
Wenjie Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins
Chad A. Dickey et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
A decade of tau transgenic animal models and beyond
Juergen Goetz et al.
BRAIN PATHOLOGY (2007)
Heat shock proteins 70 and 90 inhibit early stages of amyloid β-(1-42) aggregation in vitro
Christopher G. Evans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein
Masahiro Waza et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Gonadal hormone modulation of hippocampal neurogenesis in the adult
LAM Galea et al.
HIPPOCAMPUS (2006)
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration
M Waza et al.
NATURE MEDICINE (2005)
Gradual alteration of mitochondrial structure and function by β-amyloids:: Importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release
AM Aleardi et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2005)
Heat shock protein 90 indirectly regulates ERK activity by affecting Raf protein metabolism
F Dou et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2005)
Sex, hormones, and Alzheimer's disease
LW Baum
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2005)
Transgenic animal models of tauopathies
VMY Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Apoptosis in oligodendrocytes is associated with axonal degeneration in P301L tau mice
C Zehr et al.
NEUROBIOLOGY OF DISEASE (2004)
Heat shock protein 90 as a molecular target for cancer therapeutics
JS Isaacs et al.
CANCER CELL (2003)
Estrogen can protect neurons: modes of action
C Behl
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
J Lewis et al.
SCIENCE (2001)
Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1
MJ Egorin et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
J Lewis et al.
NATURE GENETICS (2000)
Share Paper
